Daily cardiology

A Physical Activity and Sitting Time Balance Index and All-Cause Mortality Risk 11.11.2024 2:43 ↓

Sitting Time Balance Index

Peripheral Arterial Disease 11.11.2024 33:58 ↓

PAD

H&H Academy in 7 minutes, Episode 4 11.11.2024 6:04 ↓

H&H in 7 minutes, 4

ESPRIT Trial 11.11.2024 6:00 ↓

ESPRIT Trial

Hypertension and Hyperlipidemia Academy No. 20 - Part 1 11.11.2024 1:23:00 ↓

20th H&H Academy Session

Industry Payments to Cardiologists 11.11.2024 5:42 ↓

Industry Payments

37th ESC 2024 Congress Coverage: OCCUPI Trial 25.10.2024 5:58 ↓

37th ESC 2024: OCCUPI Trial

36th ESC 2024 Congress Coverage: SWEDEGRAFT Trial 25.10.2024 6:29 ↓

36th ESC 2024: SWEDEGRAFT Trial

35th ESC 2024 Congress Coverage: RIGHT Trial 25.10.2024 4:59 ↓

35th ESC 2024: RIGHT Trial

28th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (1) 20.10.2024 10:36 ↓

28th ESC 2024: ESC 2024 CCS Guideline (1)

33rd ESC 2024 Congress Coverage: MATTERHORN Trial 20.10.2024 10:46 ↓

32nd ESC 2024: MATTERHORN Trial

29th ESC 2024 Congress Coverage: Noise and Air Pollution as Risk Factors for Hypertension 20.10.2024 4:29 ↓

29th ESC 2024: Noise and Air Pollution as RF for HTN

32nd ESC 2024 Congress Coverage: Three Biomarkers and 30-Year Cardiovascular Outcomes in Women 20.10.2024 5:49 ↓

32nd ESC 2024: Cardiovascular Outcomes in Women

31st ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (3) 20.10.2024 21:17 ↓

31st ESC 2024: ESC 2024 CCS Guideline (3)

30th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (2) 20.10.2024 21:57 ↓

30th ESC 2024: ESC 2024 CCS Guideline (2)

34th ESC 2024 Congress Coverage: Ticagrelor monotherapy vs. dual antiplatelet therapy 19.10.2024 6:22 ↓

34th ESC 2024: Ticagrelor monotherapy vs. dual antiplatelet therapy

22nd ESC 2024 Congress Coverage: NOTION-3 Trial 12.10.2024 6:46 ↓

22nd ESC 2024: NOTION-3 Trial

24th ESC 2024 Congress Coverage: EPIC-CAD Trial 12.10.2024 4:52 ↓

24th ESC 2024: EPIC-CAD Trial

26th ESC 2024 Congress Coverage: Lowering of non–high-density lipoprotein cholesterol after MI 12.10.2024 7:11 ↓

26th ESC 2024: Lowering of non-HDL cholesterol after MI and prognosis

25th ESC 2024 Congress: ESC 2024 Guideline for Management of Peripheral Arterial and Aortic Diseases 12.10.2024 14:26 ↓

25th ESC 2024: ESC 2024 PAAD Guideline

27th ESC 2024 Congress Coverage: Women in Cardiology, RISE Conference 12.10.2024 2:58 ↓

27th ESC 2024: RISE Conference

23rd ESC 2024 Congress Coverage: QUADRO Trial 12.10.2024 6:16 ↓

23rd ESC 2024: QUADRO Trial

21st ESC 2024 Congress Coverage: PALISADE Trial 11.10.2024 4:10 ↓

21st ESC 2024: PALISADE Trial

19th ESC 2024 Congress Coverage: Stop-or-Not Trial 02.10.2024 5:42 ↓

19th ESC 2024: Stop-or-Not Trial

20th ESC 2024 Congress Coverage: OCEANIC-AF Trial 02.10.2024 5:08 ↓

20th ESC 2024: OCEANIC-AF Trial